OSCR

PSEN1 Expression Identifies a Developmentally Distinct Favourable-Prognosis State in SHH α Medulloblastoma.

Overview

  1. Cancer and Neurobiology Laboratory, Experimental Research Center, Clinical Hospital (CPE‐HCPA) Federal University of Rio Grande do Sul Porto Alegre Brazil
  2. National Science and Technology Institute for Children's Cancer Biology and Pediatric Oncology—INCT BioOncoPed Porto Alegre Brazil
  3. Department of Biology Edge Hill University Ormskirk UK
  4. Children's Cancer Institute (ICI) Porto Alegre Brazil
  5. Department of Pharmacology, Institute for Basic Health Sciences Federal University of Rio Grande do Sul Porto Alegre Brazil
  6. Center for Biotechnology Federal University of Rio Grande do Sul Porto Alegre Brazil
Dates: received 6 July 2026; accepted 3 September 2026; published online 14 September 2026; in print October 2026
Type: Research article · Language: English
License: CC BY
Identifiers: DOI 10.1002/jdn.70178 · PMID 42735931 · PMCID PMC13574531 · OpenAlex W7212979576
Open access: hybrid, a free copy (OpenAlex)
Categories: human (organism), other condition (population), clinical / translational (subfield)
Methods: Statistics, Smoothing, state filtering, decompositions, Machine learning, Connectivity
Keywords: brain tumour, medulloblastoma, paediatric brain cancer, presenilin‐1, PSEN1, sonic hedgehog
MeSH: Cerebellar Neoplasms*, Hedgehog Proteins*, Medulloblastoma*, Presenilin-1*, Cerebellum, Child, Female, Gene Expression Regulation, Neoplastic, Humans, Male, Prognosis (* major topic)
Topic: Hedgehog Signaling Pathway Studies (Molecular Biology, Biochemistry, Genetics and Molecular Biology), according to OpenAlex
Citations: not cited yet (Europe PMC); 38 references in the paper

Abstract

Background: Although PSEN1 is best known for its role in Alzheimer's disease, it also regulates neural development and cerebellar morphogenesis. Medulloblastoma (MB) is the most common malignant paediatric brain tumour and arises from disrupted cerebellar developmental programmes. The clinical significance of PSEN1 in MB remains unknown. We investigated the prognostic value and transcriptional correlates of PSEN1 expression across molecular subgroups and subtypes of MB.

Methods: Public bulk and single‐cell transcriptomic datasets were used to examine PSEN1 expression, associations with overall survival (OS) and transcriptional correlates in MB. The SHH α‐associated transcriptional pattern was evaluated in an independent cohort, and PSEN1 expression was further examined in the developing human cerebellum and across paediatric brain tumour types. Genes strongly correlated with PSEN1 in SHH α MB were subjected to gene ontology (GO) enrichment analysis.

Results: High PSEN1 expression was consistently associated with significantly longer OS exclusively in SHH α MB. The PSEN1‐associated transcriptional pattern was reproduced in an independent SHH α cohort. PSEN1 was expressed across developing cerebellar cell populations and paediatric brain tumour types, with MB showing intermediate expression among the tumour entities examined. In SHH α MB, PSEN1 was associated with a coordinated transcriptional programme enriched for RNA homeostasis, intracellular membrane trafficking, protein quality control, lipid and calcium signalling and developmental pathways.

Conclusions: High PSEN1 expression identifies a favourable‐prognosis subset of SHH α MB and is associated with a distinct transcriptional programme related to endomembrane organization and cellular homeostasis rather than canonical SHH signalling. These findings suggest that PSEN1 may mark a developmentally distinct tumour state and generate new hypotheses regarding subtype‐specific developmental programmes in MB.

Reproduced under the paper's license (CC BY), from the paper cited above.

Code

The paper links to its data and to no code of its authors: see the Data section.

The paper's code and data availability statement is in the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none, so it has no map.

Data

Datasets cited

Data Availability Statement

The tumour dataset used in this study is available in the Gene Expression Omnibus (GEO) repository, accession numbers GSE202043, https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE202043, GSE85217, https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE85217, and GSE156053, https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE156053. The SHH MB RNA‐sequencing dataset described by Skowron et al. (2021) is available from the European Genome‐Phenome Archive (EGA) under accession number EGAD00001006305 (https://ega‐archive.org/datasets/EGAD00001006305 (https://ega-archive.org/datasets/EGAD00001006305)). The integrated MB transcriptomic dataset described by Arora et al. (2026) was generated from publicly available RNA‐sequencing datasets deposited under accession numbers E‐MTAB‐6814 (https://www.ebi.ac.uk/biostudies/arrayexpress/studies/E‐MTAB‐6814 (https://www.ebi.ac.uk/biostudies/arrayexpress/studies/E-MTAB-6814)), GSE109381 (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE109381), EGAS00001002696 (https://ega‐archive.org/studies/EGAS00001002696 (https://ega-archive.org/studies/EGAS00001002696)), EGAS00001000254 (https://ega‐archive.org/studies/EGAS00001000254 (https://ega-archive.org/studies/EGAS00001000254)), EGAD00001006305 (https://ega‐archive.org/dacs/EGAC00001001002 (https://ega-archive.org/dacs/EGAC00001001002)) and EGAS00001005826 (https://ega‐archive.org/studies/EGAS00001005826 (https://ega-archive.org/studies/EGAS00001005826)). The MB scRNA‐seq single cell dataset is available at the Pediatric Neuro‐oncology Cell Atlas (https://www.pneuroonccellatlas.org/). Single‐nucleus RNA‐sequencing data from the developing human cerebellum reported by Aldinger et al. (2021) were obtained through the CELLxGENE collection Spatial and cell‐type transcriptional landscape of human cerebellar development (https://cellxgene.cziscience.com/collections/1b014f39‐f202‐45ae‐bb7d‐9286bddd8d8b (https://cellxgene.cziscience.com/collections/1b014f39-f202-45ae-bb7d-9286bddd8d8b)). The independent developing human cerebellum dataset reported by Sepp et al. (2024) was obtained from the human snRNA‐seq dataset in the CELLxGENE collection Cellular development and evolution of the mammalian cerebellum (https://cellxgene.cziscience.com/e/bab7432a‐5cfe‐45ea‐928c‐422d03c45cdd.cxg/ (https://cellxgene.cziscience.com/e/bab7432a-5cfe-45ea-928c-422d03c45cdd.cxg/)). PSEN1 expression across paediatric brain tumour types was examined using RNA‐sequencing data from the Open Pediatric Brain Tumor Atlas (OpenPBTA; https://github.com/AlexsLemonade/OpenPBTA‐analysis (https://github.com/AlexsLemonade/OpenPBTA-analysis)).

Reproduced under the paper's license (CC BY), from the paper cited above.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 1, 1 October 2026: the first record

Recorded: type, language, journal, volume, issue, pages, dates, 7 authors, 6 keywords, 11 MeSH terms, 2 funders, 38 references.

Cite

This paper

Vanini, J., Thomaz, A., Lupatini, M. M., Brunetto, A. T., de Farias, C. B., Jaeger, M., & Roesler, R. (2026). PSEN1 Expression Identifies a Developmentally Distinct Favourable-Prognosis State in SHH α Medulloblastoma. International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience, 86(6), e70178. https://doi.org/10.1002/jdn.70178

BibTeX

@article{vanini2026psen1,
author = {Vanini, Julia and Thomaz, Amanda and Lupatini, Marina Müller and Brunetto, André T. and de Farias, Caroline Brunetto and Jaeger, Mariane and Roesler, Rafael},
title = {{PSEN1 Expression Identifies a Developmentally Distinct Favourable-Prognosis State in SHH α Medulloblastoma}},
journal = {International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience},
year = {2026},
month = oct,
volume = {86},
number = {6},
pages = {e70178},
publisher = {Wiley},
issn = {0736-5748},
doi = {10.1002/jdn.70178},
url = {https://doi.org/10.1002/jdn.70178},
pmid = {42735931},
pmcid = {PMC13574531}
}

RIS

TY - JOUR
AU - Vanini, Julia
AU - Thomaz, Amanda
AU - Lupatini, Marina Müller
AU - Brunetto, André T.
AU - de Farias, Caroline Brunetto
AU - Jaeger, Mariane
AU - Roesler, Rafael
TI - PSEN1 Expression Identifies a Developmentally Distinct Favourable-Prognosis State in SHH α Medulloblastoma
T2 - International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience
J2 - Int J Dev Neurosci
PY - 2026
DA - 2026/10/01
VL - 86
IS - 6
SP - e70178
SN - 0736-5748
PB - Wiley
DO - 10.1002/jdn.70178
UR - https://doi.org/10.1002/jdn.70178
LA - en
ER -

CSL-JSON

{
"id": "10.1002/jdn.70178",
"type": "article-journal",
"title": "PSEN1 Expression Identifies a Developmentally Distinct Favourable-Prognosis State in SHH α Medulloblastoma",
"container-title": "International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience",
"author": [
{
"family": "Vanini",
"given": "Julia"
},
{
"family": "Thomaz",
"given": "Amanda"
},
{
"family": "Lupatini",
"given": "Marina Müller"
},
{
"family": "Brunetto",
"given": "André T."
},
{
"family": "de Farias",
"given": "Caroline Brunetto"
},
{
"family": "Jaeger",
"given": "Mariane"
},
{
"family": "Roesler",
"given": "Rafael"
}
],
"container-title-short": "Int J Dev Neurosci",
"volume": "86",
"issue": "6",
"page": "e70178",
"DOI": "10.1002/jdn.70178",
"PMID": "42735931",
"PMCID": "PMC13574531",
"ISSN": "0736-5748",
"publisher": "Wiley",
"URL": "https://doi.org/10.1002/jdn.70178",
"language": "en",
"issued": {
"date-parts": [
[
2026,
10,
1
]
]
}
}

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.3390/cells14020072
Modulation of Stemness and Differentiation Regulators by Valproic Acid in Medulloblastoma Neurospheres.
Journal: Cells
In common: other condition, 5 references, 4 authors
[2] doi:10.3390/brainsci15070746
GABAergic Influences on Medulloblastoma.
Journal: Brain sciences
In common: other condition, 16 references, author Rafael Roesler
[3] doi:10.1007/s12017-026-08935-8
Subgroup-Specific Associations of GRIA Genes Encoding AMPA Glutamate Receptor Subunits with Patient Survival in Medulloblastoma.
Journal: Neuromolecular medicine
In common: other condition, 13 references
[4] doi:10.1038/s41388-024-02967-9
Heterogeneity and tumoral origin of medulloblastoma in the single-cell era.
Journal: Oncogene
In common: other condition, 10 references
[5] doi:10.1242/dmm.050323 [code]
PTCH1-mutant human cerebellar organoids exhibit altered neural development and recapitulate early medulloblastoma tumorigenesis.
Journal: Disease models & mechanisms
In common: other condition, 10 references
[6] doi:10.3390/brainsci14111146
High Expression of GABA<sub>A</sub> Receptor β Subunit Genes Is Associated with Longer Overall Survival in Medulloblastoma.
Journal: Brain sciences
In common: other condition, 6 references, author Rafael Roesler
[7] doi:10.3390/ijms23179852
Chromosomal Instability Characterizes Pediatric Medulloblastoma but Is Not Tolerated in the Developing Cerebellum.
Journal: International journal of molecular sciences
In common: other condition, 9 references
[8] doi:10.1016/j.isci.2023.107831 [code]
KMT2D suppresses Sonic hedgehog-driven medulloblastoma progression and metastasis.
Journal: iScience
In common: other condition, 9 references
[9] doi:10.1186/s40478-025-02055-3
Melanoma antigens in pediatric medulloblastoma contribute to tumor heterogeneity and species-specificity of group 3 tumors.
Journal: Acta neuropathologica communications
In common: other condition, 9 references
[10] doi:10.1111/cas.15691
Recent advances in the molecular understanding of medulloblastoma.
Journal: Cancer science
In common: other condition, 8 references

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: code errors and mismatches between the code and the paper about this paper and its code, from readers and its authors, beside the paper and its tracing map.

Reproductions: reports from readers who ran the authors' code and did not get the paper's result, what they ran, with which environment, commit and data.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.